Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03980769Phase 2Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
PrincipalinvestigatorStart date: 2021-05-05
NCT00008450Phase 1Completed
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
Adenosine Deaminase DeficiencyAutosomal Recessive DisorderImmune System Disorder+4 more
PrincipalinvestigatorStart date: 1997-08-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Kozono, MD, PhD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Immune System Diseases

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Gail Gauvreau, PhD

McMaster University

Related
12 trials

Shared therapeutic areas:

Immune System Diseases
Similarity Score3%

A G Elsayed, PHD

Cairo University

Related
3 trials

Shared therapeutic areas:

Immune System Diseases
Similarity Score3%

Anne Huyhn, Dr

Institut Universitaire du Cancer - Oncopole - Toulouse

Related
1 trials

Shared therapeutic areas:

Immune System Diseases
Similarity Score3%

Morton J. Cowan, MD

University of California, San Francisco

Related
4 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

K. Scott Baker

Fairview University Medical Center

Related
3 trials

Shared therapeutic areas:

Severe Combined Immunodeficiency
Similarity Score3%

Dimana Dimitrova, M.D.

National Cancer Institute (NCI)

Related
4 trials

Shared therapeutic areas:

Immune System Diseases

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Immune System Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Jordan Milner, MD

University of Florida

Related
4 trials

Shared therapeutic areas:

Severe Combined Immunodeficiency
Similarity Score3%

David T Mauger, PhD

Penn State University

Related
2 trials

Shared therapeutic areas:

Immune System Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03980769Phase 2PrincipalInvestigator

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
Recruiting
NCT00008450Phase 1PrincipalInvestigator

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Adenosine Deaminase DeficiencyAutosomal Recessive DisorderImmune System Disorder+4 more
Completed
NCT00553098Phase 2PrincipalInvestigator

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders

Immunodeficiency SyndromeNon-Cancer Diagnosis
Completed

All 3 trials loaded